Taking glioma as an example, there is a variety of mutations in oncogenes and tumor suppressor genes that lead to the development and progression of brain tumors5, such as IDH1/IDH2 mutations, 1p/19q co-deletion, telomerase reverse transcriptase (TERT) promoter mutations, and histone H3 alterations. This evidence concerns the gene IDH1 and central nervous system cancer.